| Authors | Takashi Ueta, Yasuo Yanagi, Yasuhiro Tamaki, Takuhiro Yamaguchi |
| Journal | Ophthalmology
(Ophthalmology)
Vol. 117
Issue 9
Pg. 1860; author reply 1860-1
(Sep 2010)
ISSN: 1549-4713 [Electronic] United States |
| PMID | 20816253
(Publication Type: Comment, Letter)
|
| Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Vascular Endothelial Growth Factor A
- Ranibizumab
|
| Topics |
- Angiogenesis Inhibitors
(administration & dosage, adverse effects)
- Antibodies, Monoclonal
(administration & dosage, adverse effects)
- Antibodies, Monoclonal, Humanized
- Choroidal Neovascularization
(drug therapy, etiology)
- Humans
- Injections
- Macular Degeneration
(complications, drug therapy)
- Ranibizumab
- Retreatment
- Risk Factors
- Stroke
(chemically induced, complications)
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
- Visual Acuity
(drug effects)
- Vitreous Body
|
